Targeting Cells. Tackling Disease at Its Root.
Biozipcode, Inc. is a research-driven biotech company built on joint research with universities. We aim to bring new diagnostic and therapeutic technologies for diabetes and other hard-to-treat diseases into real-world care.
Our R&D has two pillars: diabetes stem cell research focused on aberrant hematopoietic stem cells thought to contribute to persistent diabetes, and Biozipcode™ cell-targeting technology designed to selectively recognize specific cells and tissues.
Our role at Biozipcode, Inc. is to move discoveries made at universities and research institutions beyond the lab—developing them into intellectual property, diagnostic technologies, therapeutic candidates, and co-development programs that can ultimately benefit patients.
Targeting Cells. Tackling Disease at Its Root.
Diabetes Stem Cell Research
We study the properties of aberrant hematopoietic stem cells thought to play a role in persistent diabetes and its complications, with the aim of developing new diagnostic and therapeutic applications.
Biozipcode™
We identify short peptide sequences that recognize specific cells and tissues and investigate their use in cell-targeted diagnostics and therapies.
New Therapeutics & Diagnostics
We turn research findings into development programs, including therapeutic candidates aimed at complete diabetes remission, biomarkers, and cell-targeted therapeutics.
Bringing research to patients.
At Biozipcode, Inc., publishing papers is not the end goal.
We aim to develop research findings into diagnostic technologies, therapeutic candidates, and cell-targeting technologies—and, together with companies and research institutions in Japan and abroad, bring them closer to patients.
About Us
Grounded in diabetes stem cell research and Biozipcode™ cell-targeting technology, we work toward treatments that address the roots of hard-to-treat diseases and new approaches to care.
We work with pharmaceutical companies, research organizations, healthcare providers, and investors to advance new treatments through collaborative research, out-licensing, and co-development.
We work to take discoveries made at universities beyond the lab and develop them into diagnostic and therapeutic technologies that reach patients.
A research-driven biotech company built on joint research with universities, translating scientific findings into new diagnostic and therapeutic technologies for real-world use.
Our team brings together expertise in medicine, life sciences, information science, and business development to advance projects from basic research toward real-world applications.
Find the locations of Biozipcode, Inc. and our collaborative research sites. Please check the access information for each site before visiting.
